1st Quarter - Report

CROSSROADS STRATEGIES, LLC for GENENTECH, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R.2810, Medicare Patient Access and Quality Improvement Act of 2013; H.R.4302, Protecting Access to Medicare Act of 2014; Medicare reimbursement issues.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2810 (113th), H.R. 4302 (113th)

Budget/Appropriations BUD

Issues related to H.R.3547, Continuing Appropriations Resolution, 2014 (P.L. 113-76) and FY2015 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3547 (113th)

Health Issues HCR

Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54); H.R.1416, Cancer Patient Protection Act of 2013; pharma supply chain issues; S.2007, Preventing Regulatory Overreach To Enhance Care Technology Act of 2014 (PROTECT Act).

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1416 (113th), S. 2007 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.